top of page
Weatherden network graphic

Clinical
Development

Regulatory

Strategy

Pharmacology

Pharmacovigilance

Clinical
Operations

Biostatistics

Collective Intelligence

Cross-functional collaboration enables an integrated strategy and design that maximizes the probability of success

Collaborate.

Build.

Succeed.

The Power of our Team

'The team has moved with remarkable speed to secure ELV001 and prepare it for later stage clinical trials'

PARTNER AT SOFINNOVA

Asset 3_edited.jpg

>75%

MD/PhDs

Asset 3_edited.jpg
Asset 3_edited.jpg

>500

Clinical trials across collective track record

Asset 3_edited.jpg

>50

Approved drugs across collective track record

Leaders by Function

Screenshot 2026-03-19 at 15.30_edited.jpg
Weatherden team section divider

Clinical Development

Weatherden team section divider

Biostatistics

Weatherden team section divider

Clinical Operations

Weatherden team section divider

Clinical Pharmacology

Weatherden team section divider

Pharmacovigilance

Weatherden team section divider

Regulatory

Weatherden team section divider

Strategy

Screenshot 2026-03-19 at 15.30_edited.jpg
Weatherden team section divider

Clinical Development

Weatherden team section divider

Biostatistics

Weatherden team section divider

Clinical Operations

Weatherden team section divider

Clinical Pharmacology

Weatherden team section divider

Pharmacovigilance

Weatherden team section divider

Regulatory

Weatherden team section divider

Strategy

Clinical Development

Engineering data-driven development trajectories through to proof-of-concept success 

Clinical Development

Engineering data-driven development trajectories through to proof-of-concept success 

Business
Leaders 

houman.webp

Houman Ashrafian
MD PhD

Co-founder &

Chairman

"Smart drug development is about effectively navigating risk in an ever-changing environment."

x

x

Go
emma.webp

Emma Tinsley
 

Co-founder &

CEO

"Clinical trials don't have to fail at the rate they do - the real problem is how poorly we understand and manage risk."

x

Go
duncan.webp

Duncan McHale
MD PhD

Co-founder &

VP Clinical Development

"Combining our proprietary AI tools with clinical science and development experience will bring new therapies to patients and value to biotech companies faster than ever.” 

Go
bry.webp

Bryony Harraway

SVP Head of Finance &

Operations

"There’s a strong scientific backbone to everything we do,  harnessing the best clinical minds to deliver evidence-driven, high‑quality clinical input that will make a genuine difference to patients."

x

Go
andrea.webp

Andrea Sotak

SVP Head of Corporate

Development & Strategy

"Great strategy in biotech comes from aligning scientific potential with commercial reality and making clear, evidence-based decisions that maximize asset value at every stage of development."

Go
philippa.webp

Philippa Egerton-Warburton

VP Head of

Business Development

"Expert-in-the-loop is now how smart drug development is done - we actively apply this principle for clients and the new companies we create.”

x

 

xx

x

Go

Industry experts.

Broad views.

Rigorous answers.

bottom of page